10-hydroxy-1-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)-10-(trifluoromethyl)anthracen-9(10H)-one hydrochloride

ID: ALA4467209

PubChem CID: 154697564

Max Phase: Preclinical

Molecular Formula: C23H21ClF3N3O2

Molecular Weight: 427.43

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cl.O=C1c2ccccc2C(O)(C(F)(F)F)c2cccc(-c3cnn(C4CCNCC4)c3)c21

Standard InChI:  InChI=1S/C23H20F3N3O2.ClH/c24-23(25,26)22(31)18-6-2-1-4-17(18)21(30)20-16(5-3-7-19(20)22)14-12-28-29(13-14)15-8-10-27-11-9-15;/h1-7,12-13,15,27,31H,8-11H2;1H

Standard InChI Key:  YYVFFNXZUQSXPG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
    7.7284   -2.6705    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.9828   -8.8859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5783   -8.1802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1693   -8.8833    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4596   -6.9543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4585   -7.7739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1665   -8.1828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1647   -6.5455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8734   -6.9507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8722   -7.7714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5807   -6.5392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2914   -6.9527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2898   -7.7698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9954   -8.1779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7031   -7.7702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7008   -6.9501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9946   -6.5456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5807   -5.7220    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9927   -5.7284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6475   -5.2449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3935   -4.4680    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5760   -4.4702    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3254   -5.2480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8069   -3.7627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6245   -3.7691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0376   -3.0682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6372   -2.3554    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8191   -2.3481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4014   -3.0535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5719   -9.5923    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.8000   -8.8885    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.3872   -9.5917    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  3  2  1  0
  4  3  1  0
  5  6  2  0
  6  7  1  0
  7 10  2  0
  9  8  2  0
  8  5  1  0
  9 10  1  0
  9 11  1  0
 10  3  1  0
  3 13  1  0
 12 11  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 11 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 19  1  0
 21 24  1  0
 24 25  1  0
 24 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
  2 30  1  0
  2 31  1  0
  2 32  1  0
M  END

Associated Targets(Human)

PDK4 Tchem Pyruvate dehydrogenase kinase isoform 4 (177 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 427.43Molecular Weight (Monoisotopic): 427.1508AlogP: 3.82#Rotatable Bonds: 2
Polar Surface Area: 67.15Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.48CX Basic pKa: 10.17CX LogP: 2.11CX LogD: 0.41
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.65Np Likeness Score: -0.24

References

1. Lee D, Pagire HS, Pagire SH, Bae EJ, Dighe M, Kim M, Lee KM, Jang YK, Jaladi AK, Jung KY, Yoo EK, Gim HE, Lee S, Choi WI, Chi YI, Song JS, Bae MA, Jeon YH, Lee GH, Liu KH, Lee T, Park S, Jeon JH, Lee IK, Ahn JH..  (2019)  Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases.,  62  (2): [PMID:30623649] [10.1021/acs.jmedchem.8b01168]

Source